4//SEC Filing
Sucampo Pharmaceuticals, Inc. 4
Accession 0001171843-17-001364
CIK 0001365216operating
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:03 PM ET
Size
7.0 KB
Accession
0001171843-17-001364
Insider Transaction Report
Form 4
Lichtlen Peter
Chief Medical Officer
Transactions
- Award
Common stock
2017-03-06+24,000→ 24,000 total - Award
Employee Stock Option (right to buy)
2017-03-06+45,000→ 314,400 totalExercise: $11.85Exp: 2027-03-02→ Class A Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Common stock granted consists of restricted stock units that vest on March 2, 2020.
- [F2]The option will vest over a four-year period, with 25% vesting on March 2, 2018 and the remaining 75% vesting in equal monthly increments over the three-year period thereafter.
Documents
Issuer
Sucampo Pharmaceuticals, Inc.
CIK 0001365216
Entity typeoperating
Related Parties
1- filerCIK 0001365216
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 5:03 PM ET
- Size
- 7.0 KB